Experimental Drug Shows Promise for Several Cancers -- ScienceNOW - 0 views
-
Charles Daney on 06 Sep 09In the first clinical proof of its kind, a drug has dramatically shrunk cancerous tumors by disrupting a key genetic pathway. But a study targeting one deadly brain cancer, medulloblastoma, ended in disappointment as the patient's once-tamed tumor quickly developed resistance to the drug and killed him.